Síndrome de Cushing, ¿fácilmente inadvertido?

Los fundamentos del diagnóstico de un cuadro que suele pasar inadvertido en atención primaria.

British Medical Journal

INDICE: 1. Referencias | 2. Referencias

Referencias

Referencias

↵ Fardet L, Petersen I, Nazareth I. Risk of cardiovascular events in people prescribed glucocorticoids with iatrogenic Cushing’s syndrome: cohort study. BMJ2012;345:e4928.Abstract/FREE Full Text

↵ Tempark T, Phatarakijnirund V, Chatproedprai S, Watcharasindhu S, Supornsilchai V, Wananukul S. Exogenous Cushing’s syndrome due to topical corticosteroid application: case report and review literature. Endocrine2010;38:328-34.CrossRefMedlineWeb of Science

↵ Fardet L, Flahault A, Kettaneh A, Tiev KP, Genereau T, Toledano C, et al. Corticosteroid-induced clinical adverse events: frequency, risk factors and patient’s opinion. Br J Dermatol2007;157:142-8.CrossRefMedlineWeb of Science

↵ Lindholm J, Juul S, Jorgensen JO, Astrup J, Bjerre P, Feldt-Rasmussen U, et al. Incidence and late prognosis of Cushing’s syndrome: a population-based study. J Clin Endocrinol Metab2001;86:117-23.Abstract/FREE Full Text

↵ Terzolo M, Reimondo G, Chiodini I, Castello R, Giordano R, Ciccarelli E, et al. Screening of Cushing’s syndrome in outpatients with type 2 diabetes: results of a prospective multicentric study in Italy. J Clin Endocrinol Metab2012;97:3467-75.Abstract/FREE Full Text

↵ Anderson GH Jr, Blakeman N, Streeten DH. The effect of age on prevalence of secondary forms of hypertension in 4429 consecutively referred patients. J Hypertens1994;12:609-15.MedlineWeb of Science

↵ Newell-Price J, Bertagna X, Grossman AB, Nieman LK. Cushing’s syndrome. Lancet2006;367:1605-17.CrossRefMedlineWeb of Science

↵ Psaras T, Milian M, Hattermann V, Freiman T, Gallwitz B, Honegger J. Demographic factors and the presence of comorbidities do not promote early detection of Cushing’s disease and acromegaly. Experimental and Clinical Endocrinology & Diabetes2011;119(1):21-5.CrossRefWeb of Science

« Página anterior